Myomo (MYO) Cash from Operations (2016 - 2025)
Myomo's (MYO) quarterly Cash from Operations came in at -$1.8 million in Q3 2025, down 22.4% on a YoY basis from -$2.4 million in Q3 2024, and up 79.37% quarter-over-quarter from -$8.9 million in Q2 2025.
Analysis
Myomo (MYO) Cash from Operations (2016 - 2025) Analysis & Trends
Myomo (MYO) has reported Cash from Operations for 10 consecutive years, with -$1.8 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Cash from Operations fell 22.4% year-over-year to -$1.8 million; the trailing twelve-month figure through Sep 2025 stood at -$10.0 million (down 11.03% YoY), and the FY2024 full-year result was -$3.3 million, up 46.7% from the prior year.
- Cash from Operations climbed to -$1.8 million in Q3 2025 per MYO's latest filing, from -$8.9 million in the prior quarter.
- Across five years, Cash from Operations topped out at $3.4 million in Q4 2024 and bottomed at -$8.9 million in Q2 2025.
- Historically, Cash from Operations has averaged -$2.2 million across 5 years, with a median of -$2.2 million in 2021.
- The widest YoY moves for Cash from Operations: up 242.87% in 2024, down 571.02% in 2024.
- Over 5 years, Cash from Operations stood at -$1.8 million in 2021, then slumped by 34.76% to -$2.5 million in 2022, then advanced by 4.4% to -$2.4 million in 2023, then surged by 242.87% to $3.4 million in 2024, then plunged by 154.34% to -$1.8 million in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered -$1.8 million, -$8.9 million, and -$2.7 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 1.06 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 1.79 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 1.26 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 651.90 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 510.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 269.20 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1.83 Mn |
| Jun 30, 2025 | -8.87 Mn |
| Mar 31, 2025 | -2.68 Mn |
| Dec 31, 2024 | 3.37 Mn |
| Sep 30, 2024 | -1.49 Mn |
| Jun 30, 2024 | -1.92 Mn |
| Mar 31, 2024 | -3.25 Mn |
| Dec 31, 2023 | -2.36 Mn |
| Sep 30, 2023 | -1.71 Mn |
| Jun 30, 2023 | -285,523.00 |
| Mar 31, 2023 | -1.82 Mn |
| Dec 31, 2022 | -2.46 Mn |
| Sep 30, 2022 | -2.80 Mn |
| Jun 30, 2022 | -2.65 Mn |
| Mar 31, 2022 | -2.32 Mn |
| Dec 31, 2021 | -1.83 Mn |
| Sep 30, 2021 | -2.21 Mn |
| Jun 30, 2021 | -3.40 Mn |
| Mar 31, 2021 | -2.11 Mn |
| Dec 31, 2020 | -1.13 Mn |